Application of multiple regression analysis in optimization of anastrozole-loaded PLGA nanoparticles

Journal of Microencapsulation

Volumn 31, Issue 2, 2014, Pages 105-114

  Kumar, Abhinesh ^a   Sawant, Krutika K ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Anastrozole; Multiple regression analysis; Nanoparticles; PLGA

Indexed keywords

ANTINEOPLASTIC AGENTS, HORMONAL; DELAYED-ACTION PREPARATIONS; LACTIC ACID; MODELS, CHEMICAL; NANOPARTICLES; NITRILES; POLYGLYCOLIC ACID; REGRESSION ANALYSIS; TRIAZOLES;

EID: 84894126928     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2013.808280     Document Type: Article

References (49)

1. Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliv Rev, 2006;58:1688-713.
2. Acharya S, Dilnawaz F, Sahoo SK. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials, 2009;30:5737-50.
3. Adinarayana K, Ellaiah P. Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. J Pharm Pharm Sci, 2002;5:272-8.
4. Ahlin P, Kristl J, Kristl A, Vrecer F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int J Pharm, 2002;239:113-20.
5. Akhnazarova S, Kafarov V. 1982. Experiment optimization in chemistry and chemical engineering. Moscow: Mir Publications.
6. Armstrong AN, James KC. 1996. Pharmaceutical experimental design and interpretation. Bristol, USA: Taylor and Francis Publishers.
7. Bolton S, Bon C. 1997. Pharmaceutical statistics: Practical and clinical applications, 3rd edn. New York: Marcel Dekker Inc.
8. Box GEP, Hunter WG, Hunter JS. 1978. Statistics for experiments. New York: John Wiley and Sons.
9. Box GEP, Wilson KB. On the experimental attainment of optimum conditions. J Roy Stat Soc, 1951;13:1-45.
10. Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly (D, L lactide-glycolide) carriers. Eur J Pharm Sci, 1999;8:99-107.
11. Chaudhari KR, Shah N, Patel H, Murthy R. Preparation of porous PLGA microspheres with thermoreversible gel to modulate drug release profile of water-soluble drug: Bleomycin sulphate. J Microencapsul, 2010;27:303-13.
12. Chowdhury S, Ellis PA. Recent advances in the use of aromatase inhibitors for women with postmenopausal breast cancer. J Br Menopause Soc, 2005;11:96-102.
13. Corrigan OI, Li X. Quantifying drug release from PLGA nanoparticulates. Eur J Pharm Sci, 2009;37:477-85.
14. Das M, Sahoo SK. Folate decorated dual drug loaded nanoparticle: Role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance. PLoS One, 2012;7:e32920.
15. De Jong WH, Borm PJ. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomed, 2008;3:133-49.
16. Derringer G, Suich R. Simultaneous optimization of several response variables. J Quality Technol, 1980;12:214-19.
17. Dubernet C. Thermoanalysis of microspheres. Thermochim Acta, 1995;248:259-69.
18. Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release, 2001;71:53-69.
19. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm, 1989;55:R1-4.
20. Jain NK, Ram A. Development and characterization of nanostructured lipid carriers of oral hypoglycemic agent: Selection of surfactants. Int J Pharm Sci Rev Res, 2011;7:125-30.
21. Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm, 2010;76:189-99.
22. Kashi TS, Eskandarion S, Esfandyari-Manesh M, Marashi SM, Samadi N, Fatemi SM, Atyabi F, Eshraghi S, Dinarvand R. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomed, 2012;7:221-34.
23. Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Coll Surf A: Physicochem Eng Aspect, 2001;182:123-30.
24. Lacoulonche F, Gamisans F, Chauvet A, Garcia ML, Espina M, Egea MA. Stability and in vitro drug release of flurbiprofen-loaded polyepsilon- caprolactone nanospheres. Drug Dev Ind Pharm, 1999;25:983-93.
25. Levison KK, Takayama K, Isowa K, Okabe K, Nagai T. Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J Pharm Sci, 1994;83:1367-72.
26. Mainardes RM, Evangelista RC. Praziquantel-loaded PLGA nanoparticles: Preparation and characterization. J Microencapsul, 2005;22:13-24.
27. Mak KWY, Yap MGS, Teo WK. Formulation and optimization of two culture media for the production of tumour necrosis factor-β in Escherichia coli. J Chem Tech Biotechnol, 1995;62:289-94.
28. Mendes GD, Hamamoto D, Ilha J, Pereira Ados S, De Nucci G. Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies. J Chromatograph, 2007;850:553-9.
29. Miller AJ. Selection of subsets of regression variables. J R Stat Soc Ser A, 1984;147:389-425.
30. Misra R, Sahoo SK. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Eur J Pharm Sci, 2010;39:152-63.
31. Montgomery DC. 2004. Introduction to factorial designs. New York: John Wiley and Sons.
32. Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, Puglisi G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm, 2006;325:172-9.
33. Nanjwade BK, Manjappa AS, Murthy RSR, Pol YD. A novel pH-triggered in situ gel for sustained ophthalmic delivery of ketorolac tromethamine. Asian J Pharm Sci, 2009;4:189-99.
34. Paolicelli P, Prego C, Sanchez A, Alonso MJ. Surface-modified PLGA-based nanoparticles that can efficiently associate and deliver virus-like particles. Nanomedicine, 2010;5:843-53.
35. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60:110-11.
36. Redhead HM, Davis SS, Illum L. Drug delivery in poly (lactideco- glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: In vitro characterisation and in vivo evaluation. J Control Release, 2001;70:353-63.
37. Sarkar K, Yang H. Encapsulation and extended release of anti-cancer anastrozole by stealth nanoparticles. Drug Deliv, 2008;15:343-6.
38. Schulz WA. 2005. Molecular biology of human cancers: An advanced student's textbook. USA: Springer.
39. Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies. Acta Biomater, 2011;7:4169-76.
40. Shah N, Chaudhari K, Dantuluri P, Murthy RS, Das S. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic ((R)) P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target, 2009;17:533-42.
41. Shi K, Cui F, Yamamoto H, Kawashima Y. Optimized formulation of high-payload PLGA nanoparticles containing insulin-lauryl sulfate complex. Drug Dev Ind Pharm, 2009;35:177-84.
42. Shirakura O, Yamada M, Hashimoto M, Ishimaru S, Takayama K, Nagai T. Particle-size design using computer optimization technique. Drug Dev Ind Pharm, 1991;17:471-83.
43. Snehalatha M, Venugopal K, Saha RN, Babbar AK, Sharma RK. Etoposide loaded PLGA and PCL nanoparticles II: Biodistribution and pharmacokinetics after radiolabeling with Tc-99m. Drug Deliv, 2008;15:277-87.
44. Thode K, Muller RH, Kresse M. Two-time window and multiangle photon correlation spectroscopy size and zeta potential analysis-highly sensitive rapid assay for dispersion stability. J Pharm Sci, 2000;89:1317-24.
45. Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy I, Hincal AA. Diclofenac sodium incorporated PLGA (50:50) microspheres: Formulation considerations and in vitro/in vivo evaluation. Int J Pharm, 2000;195:179-88.
46. Wagner JM, Shimshak DG. Stepwise selection of variables in data envelopment analysis: Procedures and managerial perspectives. Eur J Oper Res, 2007;180:57-67.
47. Yadav KS, Sawant KK. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. Aaps Pharmscitech, 2010;11:1456-65.
48. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release, 1999;59:299-307.
49. Yee L, Blanch HW. Defined media optimization for growth of recombinant Escherichia coli X90. Biotechnol Bioeng, 1993;41:221-30.